We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
(-42%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-73.58%
Top 10 Holdings %
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$3.58M |
| 2 |
AutoZone
AZO
|
+$3.03M |
| 3 |
Howmet Aerospace
HWM
|
+$2.87M |
| 4 |
ANSS
Ansys
ANSS
|
+$2.84M |
| 5 |
Gartner
IT
|
+$2.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$7.61M |
| 2 |
General Motors
GM
|
+$6.29M |
| 3 |
Bunge Global
BG
|
+$5.38M |
| 4 |
Qualcomm
QCOM
|
+$5M |
| 5 |
US Foods
USFD
|
+$4.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Healthcare | 20.5% |
| 3 | Financials | 14.07% |
| 4 | Industrials | 12.62% |
| 5 | Consumer Discretionary | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Remitly
RELY
$4.93B
| $612K | 0.09% |
55,018
+16,162
| +42% | +$169K |
|
377
Vontier
VNT
$4.56B
| $610K | 0.09% |
36,484
-67,202
| -65% | -$1.5M |
|
378
Dole
DOLE
$1.37B
| $606K | 0.09% |
83,030
+67,730
| +443% | +$602K |
|
379
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $606K | 0.09% |
7,472
-4,008
| -35% | -$320K |
|
380
Robert Half
RHI
$4.14B
| $603K | 0.09% |
7,879
-31,449
| -80% | -$2.46M |
|
|
CPRX
381
DELISTED
Catalyst Pharmaceutical
CPRX
| $602K | 0.09% |
46,943
+7,748
| +20% | +$91.8K |
|
382
Helmerich & Payne
HP
$3.35B
| $598K | 0.09% |
16,188
-11,726
| -42% | -$493K |
|
383
Sana Biotechnology
SANA
$893M
| $598K | 0.09% |
99,659
-52,076
| -34% | -$376K |
|
384
Cable One
CABO
$236M
| $596K | 0.09% |
+699
| New | +$863K |
|
385
Energy Recovery
ERII
$415M
| $596K | 0.09% |
27,402
-23,612
| -46% | -$532K |
|
386
Matsons
MATX
$6.11B
| $594K | 0.09% |
9,651
-4,648
| -33% | -$357K |
|
387
Accenture
ACN
$106B
| $592K | 0.09% |
2,300
-1,400
| -38% | -$405K |
|
388
Royal Caribbean
RCL
$87.3B
| $591K | 0.09% |
15,600
-10,500
| -40% | -$425K |
|
389
Flowers Foods
FLO
$1.57B
| $590K | 0.09% |
+23,906
| New | +$646K |
|
390
Norwegian Cruise Line
NCLH
$9.66B
| $584K | 0.09% |
+51,449
| New | +$678K |
|
391
Collegium Pharmaceutical
COLL
$1.17B
| $582K | 0.09% |
36,300
-21,711
| -37% | -$383K |
|
392
American Well
AMWL
$183M
| $581K | 0.09% |
+8,088
| New | +$708K |
|
393
Cohen & Steers
CNS
$4.23B
| $581K | 0.09% |
+9,276
| New | +$663K |
|
394
DigitalBridge
DBRG
$2.93B
| $580K | 0.09% |
+46,359
| New | +$893K |
|
|
FMTX
395
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $580K | 0.09% |
29,063
-77,601
| -73% | -$1.02M |
|
396
Compass
COMP
$8.84B
| $579K | 0.09% |
249,641
-127,766
| -34% | -$454K |
|
397
First Majestic Silver
AG
$7.64B
| $578K | 0.09% |
+75,914
| New | +$566K |
|
398
Louisiana-Pacific
LPX
$5.19B
| $578K | 0.09% |
11,296
-9,728
| -46% | -$553K |
|
399
Lindsay Corp
LNN
$1.14B
| $576K | 0.09% |
4,021
-4,015
| -50% | -$608K |
|
400
Capri Holdings
CPRI
$1.82B
| $575K | 0.09% |
14,962
-16,527
| -52% | -$772K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q3 2022 Portfolio in Review
As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.
- PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
- PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
- PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
- PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
- PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
- PDT Partners opened 248 new positions and closed 358 in Q3 2022.
- PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.
Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.